Intuitive Surgical

ISRG · NASDAQ · USD

$391.95−2.32%−$9.29

Close · October 2, 2026

At a glance

Revenue growth
+20.51%
2025 vs 2024
Net income growth
+22.97%
2025 vs 2024
Net margin
28.4%
2024: 27.8%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Total revenue2,8922,7712,8662,5052,4402,2532,4142,0382,0101,8911,9281,744
Cost of revenue932940962843822796771664637645651577
Gross profit1,9601,8311,9041,6621,6181,4581,6421,3741,3731,2451,2771,167
Selling, general and administrative618613687573561563613511525492567452
Research and development371362353329313316295286280285260249
Operating income972855864760743578735577567469450466
EBIT972855864760743578735577567469450466
EBITDA1,2031,0551,021920908728853694679579554574
Pre-tax income1,055940956855832669810671655539516522
Income tax231114156146168-35.2122100123-8.9-94.8102
Net income818822795704658698686565527545606416
Net income to common shareholders818822795704658698686565527545606416
Basic EPS2.312.312.241.981.841.951.921.591.481.541.721.18
Diluted EPS2.292.282.201.951.811.921.891.561.461.511.691.16
Average shares (basic)354355355357359358356356355354352352
Average shares (diluted)357360360362364365364363361361358358